Circulating Extracellular Vesicles Contain miRNAs and are Released as Early Biomarkers for Cardiac Injury

J Cardiovasc Transl Res. 2016 Aug;9(4):291-301. doi: 10.1007/s12265-016-9705-1. Epub 2016 Jul 6.

Abstract

Plasma-circulating microRNAs have been implicated as novel early biomarkers for myocardial infarction (MI) due to their high specificity for cardiac injury. For swift clinical translation of this potential biomarker, it is important to understand their temporal and spatial characteristics upon MI. Therefore, we studied the temporal release, potential source, and transportation of circulating miRNAs in different models of ischemia reperfusion (I/R) injury. We demonstrated that extracellular vesicles are released from the ischemic myocardium upon I/R injury. Moreover, we provided evidence that cardiac and muscle-specific miRNAs are transported by extracellular vesicles and are rapidly detectable in plasma. Since these vesicles are enriched for the released miRNAs and their detection precedes traditional damage markers, they hold great potential as specific early biomarkers for MI.

Keywords: Biomarkers; Circulating microRNA; Exosomes; Extracellular vesicles; Myocardial infarction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Extracellular Vesicles / metabolism*
  • Female
  • Genetic Markers
  • Isolated Heart Preparation
  • Male
  • Mice, Inbred C57BL
  • MicroRNAs / blood
  • MicroRNAs / genetics*
  • Myocardial Infarction / blood
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / genetics*
  • Myocardial Reperfusion Injury / blood
  • Myocardial Reperfusion Injury / diagnosis
  • Myocardial Reperfusion Injury / genetics*
  • Sus scrofa
  • Time Factors

Substances

  • Genetic Markers
  • MicroRNAs